NCT05928806
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05928806
Title Advanced Renal Cell Cancer Combination ImmunoThErapy Clinical Trial (ARCITECT)
Acronym ARCITECT
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Michael B. Atkins, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field